NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Medicines Update

For all prescribers and health professionals both in primary care and the acute sector.

News and information blog from ADTC covering clinical topics for all sectors of the NHS.

All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site.  Click here for an index to all previous editions.  If you would like a copy of a previous edition, please contact  medicines.update@ggc.scot.nhs.uk

Alogliptin: DPP-4 Inhibitor of Choice

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Diabetes

The position of alogliptin in the NHSGGC Formulary has changed.  The previous prescribing restriction limiting use in dual therapy has been remov...

Read More...

Fast acting insulin aspart

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Diabetes

Fast acting Insulin aspart (Fiasp®) has been accepted by the SMC and added to the Formulary. It is a modified formulation of insulin aspart with the property of more rapid absorption of insulin from subcutaneous injection site than standard...

Read More...

Tiotropium: Braltus Zonda

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Respiratory

In April 2017, the ADTC accepted the Respiratory MCN’s recommendation on tiotropium inhaler devices. Braltus® Zonda Inhaler is now the preferred brand of tiotropium inhaler. Spiriva Respimat® remains a Total Formulary option. ...

Read More...

Butec (buprenorphine) patch

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Opioids

Butec® is the NHSGGC preferred brand of buprenorphine 7 day transdermal patch across primary and secondary care. It is restricted to specialist use only in elderly patients (over 65 years) where standard analgesic options are ineffective or...

Read More...

GGC Lipid Guideline Update

Posted: May 26, 2017.
Category - Medicines Update

This blog summarises the main changes of the cholesterol guidelines updated in 2017

Read More...

Vitamin D: updated resources

Posted: May 19, 2017.
Category - Medicines Update
Tagged with - Osteoporosis

NHSGGC Osteoporosis Strategy Group has produced a clinical guideline on the

Read More...

Mefenamic acid: price increase

Posted: May 19, 2017.
Category - Medicines Update
Tagged with - NSAIDs

The May Drug Tariff price for mefenamic acid has increased significantly. <...

Read More...

Bisphosphonates: Oral Health

Posted: May 19, 2017.
Category - Medicines Update
Tagged with - Osteoporosis

Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw– new guidance and the role of prescribers and dispensers   Patients who are taking anti-resorptive or anti-a...

Read More...

Warfarin and miconazole oral gel potential interaction

Posted: May 18, 2017.
Category - Medicines Update

In June 2016 the Medicines and Healthcare products Regulatory Agency (MHRA) highlighted the potentially serious clinical consequences of the interaction between miconazole oral gel and warfarin. As the Glasgow & Clyde Anticoagulant Service...

Read More...

Buprenorphine prescribing

Posted: May 05, 2017.
Category - Medicines Update
Tagged with - Opioids

The NHSGGC Substitute Prescribing Management Group has decided to change from Suboxone® (buprenorphine and naloxone) to generic single agent buprenorphine 0.4mg, 2mg and 8mg sublingual tablets across all Addiction servic...

Read More...